Editorial · 2018 · Open access

Social media and clinical trials: The pros and cons gain context when the patient is at the center

Michael A. Thompson, Ruth M O’Regan

Cancer, 124(24), 4618–4621 · Published 19 October 2018 · DOI 10.1002/cncr.31747

Open PDFView at the publisherCite this paper

In brief

“Social media and clinical trials: The pros and cons gain context when the patient is at the center” is an 2018 editorial by Michael A. Thompson and Ruth M O’Regan, published in Cancer. OpenAlex counts 24 citations as of 22 November 2026. It is open access: the full text is free to read at Cancer.

Citations
24
Most cited in
2023 (5)
References
7
Authors
2

Abstract

Social media is a useful tool for increasing awareness and disseminating information about clinical trials. However, risks include issues with confidentiality, privacy, and integrity of clinical trials.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Thompson, M. A., & O’Regan, R. M. (2018). Social media and clinical trials: The pros and cons gain context when the patient is at the center. Cancer, 124(24), 4618–4621. https://doi.org/10.1002/cncr.31747

MLA 9

Thompson, Michael A., and Ruth M O’Regan. “Social media and clinical trials: The pros and cons gain context when the patient is at the center.” Cancer, vol. 124, no. 24, 2018, pp. 4618–4621. https://doi.org/10.1002/cncr.31747.

Chicago

Thompson, Michael A. and Ruth M O’Regan. 2018. “Social media and clinical trials: The pros and cons gain context when the patient is at the center.” Cancer 124 (24): 4618–4621. https://doi.org/10.1002/cncr.31747.

Harvard

Thompson, M. A. and O’Regan, R. M. (2018) ‘Social media and clinical trials: The pros and cons gain context when the patient is at the center’, Cancer, 124(24), pp. 4618–4621. doi:10.1002/cncr.31747.

IEEE

M. A. Thompson and R. M. O’Regan, “Social media and clinical trials: The pros and cons gain context when the patient is at the center,” Cancer, vol. 124, no. 24, pp. 4618–4621, 2018, doi: 10.1002/cncr.31747.

BibTeX

@article{thompson2018social,
  title     = {{Social media and clinical trials: The pros and cons gain context when the patient is at the center}},
  author    = {Thompson, Michael A. and O’Regan, Ruth M},
  journal   = {Cancer},
  year      = {2018},
  volume    = {124},
  number    = {24},
  pages     = {4618--4621},
  doi       = {10.1002/cncr.31747},
  url       = {https://doi.org/10.1002/cncr.31747}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201911
202033
202144
202233
202355
202433
202533
202622

Topic and keywords

Social Sciences › Social Sciences › Health › Social Media in Health Education

  • social media
  • clinical trials
  • patient-centered care
  • clinical trial awareness
  • confidentiality
  • privacy
  • data integrity
  • patient engagement

Work with this paper

Most-cited papers in Social Sciences

All highly cited Social Sciences papers

Questions about this paper

How do I cite this paper in APA style?

Thompson, M. A., & O’Regan, R. M. (2018). Social media and clinical trials: The pros and cons gain context when the patient is at the center. Cancer, 124(24), 4618–4621. https://doi.org/10.1002/cncr.31747

How many times has this paper been cited?

24 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Cancer: sign in and open the PDF from this page.

Who wrote this paper?

Michael A. Thompson, Ruth M O’Regan.

What is the DOI of this paper?

10.1002/cncr.31747, permanently at https://doi.org/10.1002/cncr.31747. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.